- Home
- TLIH vs IGC Comparison
TLIH vs IGC Comparison
Compare TLIH & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLIH
- IGC
- Stock Information
- Founded
- TLIH 1998
- IGC 2005
- Country
- TLIH Singapore
- IGC United States
- Employees
- TLIH N/A
- IGC N/A
- Industry
- TLIH
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- TLIH
- IGC Health Care
- Exchange
- TLIH Nasdaq
- IGC Nasdaq
- Market Cap
- TLIH 29.1M
- IGC 33.8M
- IPO Year
- TLIH 2025
- IGC N/A
- Fundamental
- Price
- TLIH $0.41
- IGC $0.39
- Analyst Decision
- TLIH
- IGC Strong Buy
- Analyst Count
- TLIH 0
- IGC 2
- Target Price
- TLIH N/A
- IGC $4.00
- AVG Volume (30 Days)
- TLIH 3.9M
- IGC 972.3K
- Earning Date
- TLIH 09-30-2025
- IGC 11-14-2025
- Dividend Yield
- TLIH N/A
- IGC N/A
- EPS Growth
- TLIH N/A
- IGC N/A
- EPS
- TLIH 0.10
- IGC N/A
- Revenue
- TLIH $51,204,304.00
- IGC $1,327,000.00
- Revenue This Year
- TLIH N/A
- IGC $3.54
- Revenue Next Year
- TLIH N/A
- IGC $15.12
- P/E Ratio
- TLIH $4.01
- IGC N/A
- Revenue Growth
- TLIH N/A
- IGC 24.95
- 52 Week Low
- TLIH $0.39
- IGC $0.25
- 52 Week High
- TLIH $7.00
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- TLIH N/A
- IGC 46.97
- Support Level
- TLIH N/A
- IGC $0.33
- Resistance Level
- TLIH N/A
- IGC $0.45
- Average True Range (ATR)
- TLIH 0.00
- IGC 0.03
- MACD
- TLIH 0.00
- IGC -0.00
- Stochastic Oscillator
- TLIH 0.00
- IGC 48.32
About TLIH Ten-League International Holdings Limited Ordinary Shares
Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment and port machinery. The company operates in Singapore and Other International Countries.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.